Necrosis is an ancient topic which gains new attraction in the research area these years.
accumulated knowledge has broadly established the concept of programmed necrosis and attracted more passion on the mechanism study that controlled and executed it. And the recognition that not only apoptosis, but also necrosis, may be actively regulated has also redefined the role of targeting necrosis in heart diseases therapy. 12 , 13 However, we cannot distinguish the regulated necrosis and passive necrosis. To what extent necrosis can be regulated and how to regulate necrosis are worthy of further study and the understanding of the molecular mechanisms regulating necrosis will help to develop the antinecrosis strategy which has extremely important significance in the heart diseases treatment. and 4 can directly activate RIP3 via TRIF, a RHIM-containing protein. 16 Moreover, RIP1 may even antagonize necrosis by activating caspase 8, the strong inhibitor of RIP3-mediated necrosis signalling.
| DEATH RECEPTOR PATHWAY OF NECROSIS

| Initiation of death receptor-mediated necrosis
Another RHIM-containing protein, DNA-dependent activator of interferon regulatory factors, DAI, also known as ZBP1, can also activate necrosis through RIP3 activation by the RHIM-RHIM interaction when cells were infected with murine cytomegalovirus (MCMV).
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RIP1 counteracts ZBP1/DAI-mediated necrosis by interrupting the interaction between ZBP1/DAI and RIP3 in an RHIM domain-dependent manner which is particularly important for the maintenance of skin homeostasis during late embryonic life and in adult mice. 18 Necrosis can inhibit HSV-1 replication in the host cells by HSV-1 protein ICP6. ICP6 forms dimers/oligomers and then recruits RIP1/ RIP3 or RIP3/RIP3 through the direct interaction with RIP1 and RIP3 by its RHIM domain to initiate a necrotic process. HSV-1 infection is markedly elevated after RIP3 deletion. (Figure 2 ).
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| Execution of death receptor-mediated necrosis
It is now clear that RIP3 activation is the key initiation step for the death receptor-mediated necrosis. But how necrosis is executed after initiation is the focused area of this frontier research now. To this end, several downstream targets of RIP3 have been found and these findings dramatically enrich the knowledge of this signalling pathway.
| MLKL
Mixed-lineage kinase domain-like protein (MLKL) is the firstly identified RIP3 substrate and the natural target of RIP3 which was found to be specifically required for the RIP3-dependent necrosis. 21, 22 When necrosis is induced, activated RIP3 binds to MLKL and subsequently phosphorylates MLKL. 21 Phosphorylated MLKL can disturb the intact structure of the plasma membranes as well as the organelle membrane and change its permeability. 10, 23, 24 The N-terminal coil-coil domain of MLKL possesses series of amino acids with positive charges and enables MLKL to interact with the negative-charged phospholipids of the plasma membrane as well as the different phosphatidylinositol phosphates within organelle membranes ( Figure 3 ).
NSA is an unique inhibitor of MLKL and disturbs the oligomerization of MLKL and the subsequent necrosis execution. 21 However, NSA can only target human MLKL which limits its functional validation in other models ( Figure 2 ).
Recently, an interesting work by Yi-Nan Gong et al implies that cells undergoing necrosis are not always headed towards death:
ESCRT-III helps preserve the plasma membrane in these cells, contributing to survival. They found that cells that exposed PS upon 
| The metabolic enzymes
The metabolic pathway is actively participant in the execution of necrosis. Several metabolic enzymes including the glycogen phosphorylase (PYGL), glutamate-ammonia ligase (GLUL) and glutamate dehydrogenase 1 (GLUD1) are found to be the downstream target of the RIP1/RIP3 necrosome. Increased interactions between endogenous RIP3 with PYGL, GLUL and GLUD1 were detected when necrosis was induced ( Figure 3) . 26, 27 The metabolic enzymes promote the generation of ROS via increasing metabolism and depletion of PYGL, GLUL and GLUD1 by means of siRNA reduced the TNF-a-induced accumulation of ROS. 26, 27 And RIP3 might be the activator of these 3 metabolic enzymes according to the results of the in vitro assay. PYGL catalysed the glycogen degradation process.
The incubation of purified PYGL and RIP3 showed that RIP3 could enhance its activity but not RIP3-K51A, which was mutated in the kinase domain. GLUL and GLUD1 function in the Glu or Gln metabolism process during oxidative phosphorylation. Deletion of either GLUL or GLUD1 by RNA interference could also protect cells form TNF+zVAD-induced necrosis. RIP3 could enhance the activity of GLUL and GLUD1 in vivo, but the direct in vitro activity needs further detection. Thus, RIP3 might promote necrosis by regulating the metabolic enzymes which enhanced energy metabolism and increased production of ROS ( Figure 3 ).
| PGAM 5 and Drp1
The mitochondrial protein phosphatase PGAM5 was also reported to be involved in RIP1/RIP3 protein complexes ( Figure 3 Figure 3 ). In another study, RIP1/RIP3 was reported to directly activate Drp1. 29 RNA viruses infection initiated assembly of the RIP1-RIP3 complex, which also activated the GTPase Drp1 and promoted mitochondrial damage and production of ROS. But the role of the mitochondrial PGAM5-Drp1 axis could not be carried out in some cell lines by several recent studies. [30] [31] [32] [33] In that case, further research is still needed to validate the function of PGAM5 in different cell lines.
| Regulation of death receptor-mediated necrosis by the post-translational modification
The post-translational modification of the RIP1/RIP3 necrosome in the death receptor-mediated necrosis plays an important role in the necrosis induction and execution. Some involved molecules have been found but a lot more remain unknown.
| Ppm1b
Protein phosphatase 1b (Ppm1b) but not protein phosphatase 1a (Ppm1a) is a RIP3 phosphatase. Recent evidence showed that Ppm1b could inhibit both necrosis caused by RIP3 auto-phosphorylation and necrosis induced by TNF-a. 34 Ppm1b could dephosphorylate RIP3
and subsequently prevent recruitment of MLKL to the RIP3 when necrosis was induced in the cells. In the ppm1b deficiency mice, necrosis was enhanced in a RIP3-dependent manner and elevated RIP3 phosphorylation was also observed when treated with TNF-a F I G U R E 2 The RIP1-independent necrosis pathway. In TLR3/4-, HSV-1-and MCMV-mediated necrosis, the RHIM domain-containing protein can interact with RIP3 directly through RHIM-RHIM interaction. In that case, RIP1 counteracts necrosis by interrupting this interaction. MCMV, murine cytomegalovirus
which confirmed the role of ppm1b in necrosis inhibition in the animal model.
| Chaperone protein
HSP90 is a molecular chaperone which modulates both the structure and function of its associated proteins. 35 It has been found that numerous kinases are the targets of HSP90, and these proteins form complexes with HSP90 and its co-chaperone CDC37. 36 RIP1 had been demonstrated to be one of the targets of HSP90. 37 The disruption of interaction between HSP90 and RIP1 resulted in the proteasome-dependent degradation of RIP1 and the subsequent block of TNF-a-induced necrosis. 38, 39 Two new studies by Jacobsen et al and 
| CHIP
CHIP (carboxyl terminus of HSP70-interacting protein; also known as STUB1) is a chaperone protein and has long been described as an apoptosis inhibitor by degrading a variety of tumour-suppressive proteins. Recent work showed that CHIP ablation generally accelerated TNF-a-mediated necrosis. 44 CHIP knockout mice showed postnatal lethality which was rescued by simultaneous knockout of RIP3.
In the mechanism study, CHIP could promote the lysosomal localization and subsequent degradation of RIP1 or RIP3 in an ubiquitindependent manner. HSP90 was also closely associated with CHIP and modulated its function. But HSP90 induced the destabilization of RIP1 and RIP3 independent of CHIP as the inhibitor of HSP90 F I G U R E 3 Downstream signalling of RIP3 and necrosis execution. RIP3 phosphorylates MLKL and promotes the formation of MLKL oligomerization. MLKL can target different kinds of membranes including plasma membrane, ER membrane and mitochondrial membrane and lead to membrane disruption. ESCRT-III preserves membrane intact and contributes to survival. RIP3 promotes mitochondrial metabolism and ROS production by activating PYGL, GLUL and GLUD1. RIP3 promotes MPTP opening and DΨ decrease by activating CaMKII activation. The RIP3-PGAM5-Drp1 cascade is supposed to be the signalling convergence for necrosis by promoting mitochondrial fission and ROS production induced the degradation of RIP1 and RIP3 even under CHIPdepleted conditions.
| MITOCHONDRIAL PATHWAY OF NECROSIS
Mitochondrial permeability transition pore (MPTP) is a multiple protein complex modulating the opening of the inner mitochondrial membrane and allowing the passage of solutes with molecular weights <1500 Da. 45 MPTP opening leads to the loss of ionic homeostasis, depleted ATP and ultimate necrotic cell death. 46 The molecular composition of MPTP is elusive probably because the MPTP is a highly dynamic complex., 47, 48 A can inhibit the opening of MPTP and ischaemia injury by preventing the MPTP from opening which provides a certain degree of protection to patients following myocardial infarction (Table 1) . 51, 52 The inducers of MPTP seem to involve Ca 2+ , ROS and other factors (Table 1) . Recently, p53 was proposed to be the strong inducer of MPTP and regulated MPTPÀmediated necrosis through direct interaction with Cypd (Table 1) . Binding of p53 would change the conformation of MPTP complex and promoted MPTP opening, but the precise mechanism was still unknown. Bak could also regulate the opening of MPTP and necrosis as the outer membrane component of MPTP. 54 In another work by Whelan RS, they showed that Bax potentiated MPTP opening by promoting mitochondrial fusion which was not dependent on its oligomeric ability. 55 Thus, Bax and Bak are widely involved in different cell death process and may be therapeutic targets for diseases involved both apoptosis and necrosis.
| SIGNALLING IN TER ACTION
Now we know that both the death receptor pathway and the mitochondrial pathway are important in the induction of necrosis. But it is currently unclear whether there is one common pathway in which these 2 necrotic pathways converge.
Lots of evidence confirmed that mitochondrial was important in the death receptor-mediated necrosis. It was commonly proposed that necrotic signalling proceeded through the TNF-a-induced accumulation of ROS. TNF-a-mediated ROS generation had been shown to be dependent on mitochondrial in L929 cells (Figure 4) . 56 With suppression of complex I of the respiratory chain, TNF-a-mediated cell death was attenuated. But inhibiting cytoplasmic ROS generation through knockdown of NADPH oxidase by siRNA did not affect TNF-a-mediated cell death ( Figure 4) . Moreover, recently, Yingying Zhang et al found that mitochondria-produced reactive oxygen species (ROS) could lead to RIP1 auto-phosphorylation and was essential for RIP3 recruitment into necrosome. 15 It was demonstrated that TNF-a was able to reduce the interaction between ANT and Cypd and impaired the function of ANT in a RIP1-dependent manner. 57, 58 The direct consequence of impaired function of ANT was the increasing ROS production and decreasing ATP production. Further evidence for the interaction of the 2 pathways was also documented that TNFa-induced necrosis was attenuated in the Cypd deficiency MEF. 10 Interestingly, the presence of Nec-1, a specific RIP1 inhibitor, also delayed opening of the MPTP in isolated cardiomyocytes subjected to oxidative stress. 59 RIP3 colocalized with mitochondria when necrosis was induced in a kinase activity-dependent manner and promoted mitochondrial metabolism and ROS production by activating the PYGL, GLUL and GLUD1, leading to the consequent necrosis as mentioned above ( Figures 3   and 4) . 60 In a recent study, Ting Zhang et al found that siRNA- double-deficient mice survived prolonged time after kidney I/R injury. 62 The direct evidence that mitochondria was likely to be dispensable for necrosis was the recent work by Doug Green's group.
They cleared the mitochondria of SVEC and 3T3 cells via mitophagy induced by the uncoupler carbonylcyanide m-chlorophenylhydrazone (CCCP) and demonstrated that TNFa-induced ROS was lost in these cells, but necrosis was still largely induced. 31 However, mitochondria could not be completely eliminated with about 20% of cells still contained some mitochondria and still contributed to the necrosis programme. Or maybe, the mitochondrial ROS was just one of the necrosis induction factor and the TNF-a-induced necrosis could still be executed without mitochondrial (Figure 4 ).
In summary, according to the existing evidence, the death receptor pathway can induce necrosis through the mitochondrial ROS and do have some interactions with the mitochondrial pathway but this seems not necessary. They can also function independently and any of the 2 pathways can regulate the necrosis separately. Further study is still needed to reveal the clear relationship between these 2 pathways.
| NECROSIS IN HEART DISE ASES
Cell death of the terminally differentiated cardiomyocytes is the major inducer of heart diseases. 63 Inhibition of apoptosis has been applied to the protection of cardiomyocytes in heart diseases. 64, 65 But the inhibition of apoptosis by caspase inhibitors during early reperfusion did not improve the post-ischaemic heart function. 66 During the heart I/R injury, both apoptosis and necrosis would happen, but Leist and his coworkers showed that loss of intracellular ATP would switch the apoptosis to necrosis. The contribution of necrosis to infarct size at 20, 25
and 30 minutes was significantly greater than that of apoptosis. Necrotic disruption of the membranes leads to release of cellular content into the extracellular space and promotes inflammatory reaction and further cell death which is not the case of apoptosis. 67 Necrosis also plays an important role in heart failure. The frequency of necrosis in heart failure models has been demonstrated early in 1999. Guerra S used the molecular probe to measure the ratio of cardiomyocyte necrosis and apoptosis in the heart failure patients including 7 women and 12 men. In this study, they found that necrosis will cause the DNA damage with blunt end fragments, whereas apoptosis would happen following the doublestrand DNA cleavage with single base or longer 3' overhangs. The final results showed that heart failure resulted in a great increase in necrosis in both women and men, and levels of cardiomyocyte necrosis were sevenfold greater than apoptosis in the heart failure patients We had no idea how to handle necrosis as it used to be considered a passive and accidental cell death before. Now, the well-established concept of programmed necrosis and its critical role in the pathogenesis of myocardial infarction, ischaemia/reperfusion injury and heart failure shed light on potential ways for treatment of heart diseases by targeting the necrotic pathways (Table 2) . 68 It is believed that necrosis will happen in 2 distinct forms: the passive necrosis and the regulated necrosis or necroptosis. But the relative proportion of unregulated versus regulated necrotic death is not currently known. So to figure out how necrosis process is progressed and which pathways are involved in the regulation of necrosis during the myocardial injury has great significance in the treatment of heart diseases. Recent evidence shows that both the death receptor pathway and the mitochondrial pathway of necrosis are involved in the pathogenesis of heart diseases.
| Death receptor-mediated necrosis in heart diseases
It has long been confirmed that TNF-a or Fas ligands are elevated in the serum of patients with heart failure. 69, 70 As necrosis can be F I G U R E 4 Signalling interaction of the death receptor pathway and mitochondrial pathway. In the death receptor pathway, TNFR can interrupt the interaction of Cypd and ANT in a RIP1-dependent manner, which produces much mitochondrial ROS. The mitochondrial ROS can promote the auto-phosphorylation of RIP1 and assembly of the necrosome while the cytoplasm ROS cannot. RIP3 can promote mitochondrial ROS production through activation of the metabolism enzymes. The mitochondrial ROS is also the key stimulator of the MPTP opening induced by the activation of the death receptors, it is not surprised that RIP1/RIP3-mediated death receptor pathway contributes to the necrosis of cardiomyocytes in heart failure patients. In the permanent myocardial ischaemia animal model, RIP3 knockout would decrease the inflammatory response and hypertrophic growth of the cells while the ejection fraction was increased. 60 It had been also observed that the markers of necrosis, phospho-MLKL, are also up regulated in the end-stage heart failure patients. 71 Until now, several important factors which are involved in the regulation of death receptor-mediated necrosis in the pathogenesis of heart patients have been revealed.
| Tak1 and Traf2
Tak1 was first identified as a transforming growth factor b-activated kinase, and it was also activated by inflammatory cytokines such as TNF-a. Tak1 was activated in the heart under the pathological stress 
Heart failure patients
Detection of different forms of DNA damages caused by apoptosis and necrosis separately 13-fold and 27-fold increase in necrosis in women and men, respectively 72 Heart failure patients
Detection of the level of death receptor TNF-a or Fas ligands are elevated in the serum of patients 76, 77 Heart failure patients Knockdown of microRNA103/107 shows a protective role during the cardiac I/R injury.
| The mitochondrial necrosis pathway in heart diseases
The opening of the MPTP is the critical determinant of necrosis induction and accounts for the major cell death in the first few minutes of reperfusion during cardiac I/R injury, contributing up to 50% of the final infarct size. 78 Deletion of Cypd markedly decreased MI size during ischaemia/reperfusion in vivo. Similarly, cyclosporine A or sanglifehrin A, which bind and inhibited the activity of Cypd, protected isolated cardiomyocytes from I/R injury and decreased infarction in isolated, perfused hearts and the myocardium in vivo in mouse model. More importantly, cyclosporine A had also been reported to improve the heart function in human.
Serum creatine kinase and infarct size were decreased in the cyclosporine A-treated patients with acute myocardial infarction. 79 Ca 2+ overload was the trigger of both MPTP opening and heart failure. Transgenic mice with overexpression of the L-type Ca 2+ channel showed myocardial necrosis and heart failure. This phenotype was rescued by the Cypd deficiency but not Bcl-2 overexpression, indicating necrosis but not apoptosis as the major cause in Ca 2+ abnormality-related pathogenesis. 80 As Cypd is the core regulator of the MPTP opening and necrosis induction in the pathogenesis of heart diseases, factors regulating the activity of Cypd has been studied intensively.
| HSP90 and HAX1
The mitochondrial chaperone protein HSP90 present a cardioprotec- of heart diseases, so we focus on the downstream signalling after the activation of death receptor. Nec-1 was a RIP1 inhibitor that binds with RIP1 specifically and antagonized the activity of RIP1. with CsA in the clinical application. 84 However, these conclusions were drawn from only few samples, and it was deserved to re-evaluate necrosis inhibition by Nec-1 and cyclosporine A in combination in different cases.
| PERSPECTIVE
Understanding of different modes of cell death due to pathologic stimuli can provide valuable knowledge about the pathophysiology.
The recognition that large proportion of necrotic death is regulated aroused great interests in the mechanism study of programmed necrosis. The plentiful and substantial research outcome about programmed necrosis has revolutionized research areas and medicine.
But until now, lots of questions remain to be answered. Firstly, how is necrosis signalling transducted? The RIP1/RIP3 complex is the core regulatory factors in necrosis induction, but the downstream signalling is largely unknown. Although some mechanism has been revealed, the more detailed mechanism remains to be further 
